Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology. The results are being presented today by the University at Buffalo researcher who led the study at the annual meeting of the European Association for the Study of Diabetes in Lisbon.

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published ...

Thu 14 Sep 17 from Medical Xpress

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients, Thu 14 Sep 17 from Eurekalert

Astra's Farxiga results may open up type 1 diabetes opportunity

FRANKFURT (Reuters) - AstraZeneca's Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up a additional market opportunity for the type-2 diabetes ...

Thu 14 Sep 17 from Reuters

Another SGLT2 Drug Shines as Insulin Adjunct in T1D (CME/CE)

(MedPage Today) -- Dapagliflozin lowered HbA1c in phase III trial

Thu 14 Sep 17 from MedPageToday

A1c, Weight Loss Benefit Seen With Exenatide-Glargine Combo

(MedPage Today) -- No increased risk for hypoglycemia reported

Tue 12 Sep 17 from MedPageToday

  • Pages: 1

Bookmark

Bookmark and Share